TAmiRNA GmbH

TAmiRNA seeks to identify and characterize small non-coding RNA molecules referred to as “microRNAs”, which contribute to the process of aging or the development of age-related diseases. Ultimately, TAmiRNA uses this knowhow to develop novel medical applications of microRNAs as diagnostic tests or therapeutic drugs to enable personalized treatment of disease.

  • Gegründet

    2013
  • Aktualisiert am

    30.05.2018